ERCC1 mRNA Levels Complement Thymidylate Synthase mRNA Levels in Predicting Response and Survival for Gastric Cancer Patients Receiving Combination Cisplatin and Fluorouracil Chemotherapy.

METZGER R; LEICHMAN C G; DANENBERG K D; DANENBERG P V; LENZ H-J; HAYASHI K; GROSHEN S; SALONGA D; LEICHMAN L

Art

J-GLOBAL ID：200902192373498520 Reference number：98A0298569

ERCC1 mRNA Levels Complement Thymidylate Synthase mRNA Levels in Predicting Response and Survival for Gastric Cancer Patients Receiving Combination Cisplatin and Fluorouracil Chemotherapy.

シスプラチンとフルオロウラシルの併用化学療法を受ける胃癌患者の反応と生存の予測において、ERCC1 mRNAレベルは、チミジル酸シンターゼmRNAレベルを補完する

Publisher site Copy service {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=98A0298569&COPY=1") }}
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=98A0298569&from=J-GLOBAL&jstjournalNo=E0307D") }}

Author (9)： , , , , , , , ,
Material：
Volume： 16 Issue： 1 Page： 309-316 Publication year： Jan. 1998
JST Material Number： E0307D ISSN： 0732-183X Document type： Article
Country of issue： United States (USA) Language： ENGLISH (EN)

, , , , , , , , ,

Return to Previous Page